AddLife AB (CHIX:ALIFBS) Cyclically Adjusted FCF per Share: kr5.70 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ALIFBS AddLife AB CHIX:ALIFBS
82 GF Score
Price kr164.00
GF Value kr150.01
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is AddLife AB Cyclically Adjusted FCF per Share?

AddLife AB CHIX:ALIFBS 82 Cyclically Adjusted FCF per Share is kr5.70 as of Jun. 2026. GuruFocus rates CHIX:ALIFBS with a GF Score™ of 82/100 and a GF Value™ of kr150.01 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

AddLife AB's adjusted free cash flow per share for the three months ended in Jun. 2026 was kr0.689. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr5.70 for the trailing ten years ended in Jun. 2026.

During the past 12 months, AddLife AB's average Cyclically Adjusted FCF Growth Rate was 16.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-09-18), AddLife AB's current stock price is kr164.00. AddLife AB's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was kr5.70. AddLife AB's Cyclically Adjusted Price-to-FCF of today is 28.79.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of AddLife AB was 34.24. The lowest was 18.88. And the median was 26.04.


AddLife AB  (CHIX:ALIFBs) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

AddLife AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=164.00/5.697
=28.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of AddLife AB was 34.24. The lowest was 18.88. And the median was 26.04.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


AddLife AB Cyclically Adjusted FCF per Share Related Terms


AddLife AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for AddLife AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AddLife AB Cyclically Adjusted FCF per Share Chart

AddLife AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.45

AddLife AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.67 4.66 5.50 5.56 5.70

CHIX:ALIFBS vs ISRG, BDX, RMD: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, AddLife AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where AddLife AB's Cyclically Adjusted Price-to-FCF falls into.


CHIX:ALIFBS
82GF Score
AddLife AB CHIX:ALIFBS
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AddLife AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AddLife AB's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.689/134.6100*134.6100
=0.689

Current CPI (Jun. 2026) = 134.6100.

AddLife AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.221 101.138 0.294
201612 0.887 102.022 1.170
201703 0.381 102.022 0.503
201706 0.263 102.752 0.345
201709 0.176 103.279 0.229
201712 0.797 103.793 1.034
201803 0.285 103.962 0.369
201806 0.148 104.875 0.190
201809 0.079 105.679 0.101
201812 0.938 105.912 1.192
201903 0.787 105.886 1.000
201906 0.416 106.742 0.525
201909 0.354 107.214 0.444
201912 1.476 107.766 1.844
202003 0.504 106.563 0.637
202006 0.998 107.498 1.250
202009 1.435 107.635 1.795
202012 4.962 108.296 6.168
202103 1.420 108.360 1.764
202106 1.320 108.928 1.631
202109 1.624 110.338 1.981
202112 3.205 112.486 3.835
202203 2.249 114.825 2.637
202206 1.109 118.384 1.261
202209 -0.310 122.296 -0.341
202212 2.660 126.365 2.834
202303 0.328 127.042 0.348
202306 0.131 129.407 0.136
202309 0.607 130.224 0.627
202312 3.422 131.912 3.492
202403 0.295 132.205 0.300
202406 1.059 132.716 1.074
202409 0.714 132.304 0.726
202412 4.866 132.987 4.925
202503 1.444 132.825 1.463
202506 0.501 133.699 0.504
202509 0.714 133.480 0.720
202512 6.778 133.380 6.841
202603 0.435 133.550 0.438
202606 0.689 134.610 0.689

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr5.70 mean?
AddLife AB (CHIX:ALIFBS) has a Cyclically Adjusted FCF per Share of kr5.70 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on AddLife AB and its competitors.
Is AddLife AB's Cyclically Adjusted FCF per Share too high?
AddLife AB's current Cyclically Adjusted FCF per Share is kr5.70. Overall, AddLife AB has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's Cyclically Adjusted FCF per Share compare to ISRG and BDX?
AddLife AB's Cyclically Adjusted FCF per Share of kr5.70 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on AddLife AB and its competitors. AddLife AB's current Cyclically Adjusted FCF per Share is kr5.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
Based on GuruFocus' analysis, AddLife AB (CHIX:ALIFBS) is currently considered Fairly Valued. The stock's GF Value™ is kr150.01, compared to a current price of kr164.00 — trading 9.3% above its estimated fair value. The current Cyclically Adjusted FCF per Share is kr5.70. AddLife AB's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For AddLife AB (CHIX:ALIFBS), the current Cyclically Adjusted FCF per Share is kr5.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AddLife AB (CHIX:ALIFBS) Overvalued in 2026?

Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued. The current stock price of kr164.00 is trading 9.3% above its estimated GF Value™ of kr150.01. GuruFocus considers AddLife AB to be Fairly Valued.

Key valuation signals for CHIX:ALIFBS:

  • Cyclically Adjusted FCF per Share: kr5.70
  • GF Value™: kr150.01 vs. price of kr164.00 (9.3% above fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ALIFBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AddLife AB Business Description

Address Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
82GF Score

Get the complete analysis for CHIX:ALIFBS

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr164.00
Price
kr150.01
GF Value